This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2020
  • /
  • 08
  • /
  • FDA approves SOMATOM On.site, a mobile head comput...
News

FDA approves SOMATOM On.site, a mobile head computed tomography (CT) scanner from Siemens Healthineers.

Read time: 1 mins
Published:8th Aug 2020
The FDA has cleared the SOMATOM On.site, a mobile head computed tomography (CT) scanner from Siemens Healthineers that enables a critically ill patient to receive CT head imaging in the intensive care unit (ICU) while remaining in bed. Performing a CT head examination at the patient’s bedside can eliminate costly transports to the radiology department, which involve high staffing requirements and potential patient risk. With the SOMATOM On.site, Siemens Healthineers enables reliable and consistent image quality at the point of care, allowing customers to transform care delivery. Normally, patients have to be moved to the CT scanner, wherever it may be within a hospital. With the SOMATOM On.site, patients that need head scans do not have to be unnecessarily disturbed, reducing the potential for injury and further aggravation of a condition during transport. Moreover, since only one person is required to move the new CT scanner from room to room, fewer clinical staff are tied up than when moving a bedridden patient..
Condition: Imaging:CT Scan
Type: drug

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.